top of page

Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder

About the study

NCT Trial Number

NCT02461927

The drug being studied

Ketamine

noun_Drug_2240951.png
noun_Institution_118530.png

Sponsored by

VA Office of Research and Development

noun_date_3237048.png

Trial Start Date

Jan-15

noun_capsule_138144.png

About the participants

Age seeking

21 Years to 65 Years

gender

All

noun_Mental Health_2683241.png

Primary condition of volunteers accepted

Depression

noun_square_138133.png

Accepts healthy volunteers?

No

This study will investigate the efficacy of ketamine vs ketamine plus naltrexone to treat depression and alcohol use disorder.

Eyes Graffiti

Locations


United States, Connecticut
VA Connecticut Healthcare System West Haven Campus, West Haven, CT

West Haven, Connecticut, United States, 06516
Contact: Gihyun Yoon, MD
203-932-5711 ext 7421
gihyun.yoon@va.gov

​

​

​

​

Get in contact

Find a study site convenient for you below, then email yourself the contact details and next steps

bottom of page